Literature DB >> 19038896

Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects.

Elisabeth M Weiss1, Christian G Kohler, Julia Vonbank, Edith Stadelmann, Georg Kemmler, Hartmann Hinterhuber, Josef Marksteiner.   

Abstract

OBJECTIVE: To investigate emotion discrimination abilities in healthy comparison subjects, patients with mild cognitive impairment (MCI), early and moderate Alzheimer disease (AD).
DESIGN: Prospective study design.
SETTING: Outpatient memory clinic, Department of Psychiatry, Innsbruck, Austria.
METHODS: One hundred forty-one subjects older than 60 years were included in the study. Thirty-five subjects were classified as healthy comparison subjects, 51 subjects as MCI (21 subjects with amnestic MCI single domain, 31 subjects with amnestic MCI multiple domain), 32 subjects with early AD and 23 subjects with moderate AD. MEASUREMENTS: All subjects were tested on an extensive neuropsychological test battery including the Penn Emotion Recognition Tests and depression symptoms were assessed additionally.
RESULTS: Healthy subjects and patients with MCI, early and moderate AD differed significantly in the recognition of all emotions and neutral faces combined. When separated by emotion, the authors found significant differences in emotion recognition between the diagnostic groups for happy, sad, fearful, and neutral faces. Compared with comparison subjects, amnestic MCI patients single domain did not differ significantly in their emotion recognition abilities, but amnestic MCI multiple domain patients were already impaired in the recognition of overall emotions, sad, fearful, and neutral faces and the deficits increased with the severity of AD. Depression had a significant influence on the recognition of overall emotion and neutral faces and increased the probability of misinterpreting neutral faces as sad leading to a negative bias.
CONCLUSIONS: Diminished abilities for emotion discrimination are already present in patients with MCI and further decreased with AD progression.

Entities:  

Mesh:

Year:  2008        PMID: 19038896     DOI: 10.1097/JGP.0b013e318186bd53

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  26 in total

1.  Emotion recognition in objects in patients with neurological disease.

Authors:  Michelle N Shiota; Michaela L Simpson; Heidi E Kirsch; Robert W Levenson
Journal:  Neuropsychology       Date:  2019-09-02       Impact factor: 3.295

2.  The same with age: Evidence for age-related similarities in interpersonal accuracy.

Authors:  Vanessa L Castro; Derek M Isaacowitz
Journal:  J Exp Psychol Gen       Date:  2018-12-13

3.  Smaller brain size likely in young adults (<40 years old) with depressive symptoms compared to healthy controls: a retrospective study.

Authors:  Michito Adachi; Akiko Shibata; Takamichi Sato; Etsuko Kawaguchi
Journal:  Jpn J Radiol       Date:  2011-01-26       Impact factor: 2.374

4.  Citalopram Ameliorates Synaptic Plasticity Deficits in Different Cognition-Associated Brain Regions Induced by Social Isolation in Middle-Aged Rats.

Authors:  Wei-Gang Gong; Yan-Juan Wang; Hong Zhou; Xiao-Li Li; Feng Bai; Qing-Guo Ren; Zhi-Jun Zhang
Journal:  Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.590

5.  Emotion recognition in frontotemporal dementia and Alzheimer's disease: A new film-based assessment.

Authors:  Madeleine S Goodkind; Virginia E Sturm; Elizabeth A Ascher; Suzanne M Shdo; Bruce L Miller; Katherine P Rankin; Robert W Levenson
Journal:  Emotion       Date:  2015-05-25

6.  Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Authors:  Paula T Trzepacz; Peng Yu; Phani K Bhamidipati; Brian Willis; Tammy Forrester; Linda Tabas; Adam J Schwarz; Andrew J Saykin
Journal:  Alzheimers Dement       Date:  2012-12-17       Impact factor: 21.566

7.  Heightened emotional contagion in mild cognitive impairment and Alzheimer's disease is associated with temporal lobe degeneration.

Authors:  Virginia E Sturm; Jennifer S Yokoyama; William W Seeley; Joel H Kramer; Bruce L Miller; Katherine P Rankin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

8.  Tocilizumab's effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer's model.

Authors:  H Kübra Elcioğlu; Ersin Aslan; Sarfraz Ahmad; Saadet Alan; Emine Salva; Ö Haluk Elcioglu; Levent Kabasakal
Journal:  Mol Cell Biochem       Date:  2016-07-22       Impact factor: 3.396

9.  Recognition of facial emotional expression in amnestic mild cognitive impairment.

Authors:  Alexandra Varjassyová; Daniel Hořínek; Ross Andel; Jana Amlerova; Jan Laczó; Kateřina Sheardová; Hana Magerová; Iva Holmerová; Martin Vyhnálek; Ondřej Bradáč; Yonas E Geda; Jakub Hort
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Yamaguchi Facial Expression-Making Task in Alzheimer's Disease: A Novel and Enjoyable Make-a-Face Game.

Authors:  Tomoharu Yamaguchi; Yohko Maki; Haruyasu Yamaguchi
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.